INTENDED FOR U.S. AUDIENCES ONLY

REIMAGINING EEG MONITORING IN HEALTHCARE FACILITIES

WIRED EEG MAY NOT BE RIGHT FOR YOUR PATIENTS

Current systems require an EEG technician for setup

1,2

They may be uncomfortable and can be distressing to patients

Motion artifacts are more frequent with wired systems and create data that can be difficult to interpret

3

PROVEN ACCURACY, FAST AND SIMPLE, WHEN AND WHERE YOU NEED IT

The simplified REMI Montage provides a simplified, accurate view of potential electrographic seizure activity, which includes individual recordings from each of the 4 REMI Sensors, as well as 6 sensor-to-sensor differential channels.

The REMI™ System has just 4 wireless sensors that are placed below the hairline on the forehead and behind the ear, giving comprehensive coverage of bipolar frontal and temporoparietal brain regions. The simple applications means that anyone can apply the sensors—an EEG technician is not needed for the process.

In one study, physicians identified 100% of electrographic seizure events recorded in at least 1 location where the REMI Sensors were placed.

IDEAL FOR USE IN MULTIPLE HEALTHCARE FACILITY SETTINGS

EMERGENCY ROOM

REMI is a rapidly deployable triage tool for seizure detection.

1,5

Epileptologists found that ≥79% of all seizures were visible at each sensor location, indicating that REMI users can expect to detect and record the vast majority of electrographic seizure activity in at least 1 location.

INTENSIVE CARE UNIT

REMI provides long-duration EEG to many patient types with neurologic emergencies and can be used to track the frequency and duration of seizures.

1,4-8

Rapid EEG may help to quickly identify an electrographic seizure event in neurologic emergencies, such as post-convulsive seizure and non-convulsive status epilepticus, suspected non-epileptic seizure, post-cardiac arrest coma, altered mental status, stroke, and risk for traumatic brain injury

1,6-8

A COST-EFFECTIVE EEG SOLUTION FOR YOUR FACILITY

Rapid EEG monitoring has been shown to have a positive impact on overall healthcare costs.

RAPID EEG MAY ALLOW THE FACILITY TO REDUCE

The Neurocritical Care Society recommends that EEG monitoring should be initiated within 15 to 60 minutes of suspected status epilepticus, or prolonged seizures, in all patients.

9

Frequency of interhospital transfers

Unnecessary use of antiseizure medications

Healthcare facility length of stay

DISCOVER THE SIMPLICITY OF SETTING UP THE REMI REMOTE EEG MONITORING SYSTEM

Consult product labeling for any indications, contraindications, warnings, cautions, and directions for use.

REMI REMOTE EEG MONITORING SYSTEM: SYNC, SET, START

REMI Mobile enables you to create a profile for each patient.

When you’re ready to monitor, simply:

SYNC

Easily link a patient profile with the REMI Sensors using REMI Mobile

Consult product labeling for any indications, contraindications, warnings, cautions, and directions for use.

SEE THE BENEFITS OF REMI FOR AMBULATORY USE

REMI FOR AMBULATORY

REMI SYSTEM SAFETY INFORMATION

INDICATIONS
REMI Remote EEG Monitoring System Indications for Use

The REMI Remote EEG Monitoring System is indicated for use in healthcare settings where near real-time and/or remote EEG is warranted and in ambulatory settings where remote EEG is warranted. REMI uses single use, single patient, disposable, wearable sensors intended to amplify, capture, and wirelessly transmit a single channel of electrical activity of the brain for a duration up to 30 days.

The REMI System uses the REMI Mobile software application that runs on qualified commercial off-the-shelf mobile computing platforms. REMI Mobile displays user setup information to trained medical professionals and provides notifications to medical professionals and ambulatory users. REMI Mobile receives and transmits data from connected REMI Sensors to the secure REMI Cloud where it is stored and prepared for review on qualified EEG viewing software.

REMI does not make any diagnostic conclusion about the subject’s condition and is intended as a physiological signal monitor. The REMI System is indicated for use with adult and pediatric patients (6+ years).

Please click here for full Instructions for Use for REMI™ Healthcare Facility and REMI™ Ambulatory.

REMI Vigilenz AI For Event Detection Indications for Use

REMI Vigilenz AI For Event Detection is indicated for the analysis of REMI Remote EEG Monitoring System electroencephalogram (EEG) recordings. REMI Vigilenz AI For Event Detection is intended to be used by physicians qualified to analyze and interpret EEG who will exercise professional judgment in using the information.

As an aide to the qualified physician’s REMI EEG review, REMI Vigilenz AI For Event Detection marks previously acquired sections of REMI EEG that may correspond to neurological events of interest indicative of potential electrographic seizures lasting at least 10 seconds in duration. REMI Vigilenz AI For Event Detection is indicated for use with adult and pediatric patients (6+ years).

REMI Vigilenz AI For Event Detection does not mark REMI EEG records in real time and does not provide any diagnostic conclusion about the patient’s condition to the user.

Please click here for full Instructions for Use for REMI Vigilenz™ AI for Event Detection.

References: 1. Davey Z, Gupta PB, Li DR, Nayak RU, Govindarajan P. Rapid response EEG: current state and future directions. Curr Neurol Neurosci Rep. 2022;22(12):839-846. doi:10.1007/s11910-022-01243-1 2. Supporting patients with sensory issues through video-EEG monitoring. Seer Medical. Accessed November 3, 2023. https://seermedical.com/eeg-sensory-issues 3. Frankel MA, Lehmkuhle MJ, Spitz MC, Newman BJ, Richards SV, Arain AM. Wearable reduced-channel EEG system for remote seizure monitoring. Front Neurol. 2021;12:728484. doi:10.3389/fneur.2021.728484 4. REMI™ Remote EEG Monitoring System. Instructions for use. Epitel, Inc.; January 2024. 5. Frankel MA, Lehmkuhle MJ, Watson M, et al. Electrographic seizure monitoring with a novel, wireless, single-channel EEG sensor. Clin Neurophysiol Pract. 2021;6:172-178. doi:10.1016/j.cnp.2021.04.003 6. Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48-61. doi:10.5698/1535-7597-16.1.48 7. Viarasilpa T, Panyavachiraporn N, Osman G, et al. Differentiation of psychogenic nonepileptic attacks from status epilepticus among patients intubated for convulsive activity. Epilepsy Behav. 2021;115:107679. doi:10.1016/j.yebeh.2020.107679 8. Panchal AR, Bartos JA, Cabañas JG, et al. Part 3: adult basic and advanced life support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2020;142(suppl 2):S366-S468. doi:10.1161/CIR.0000000000000916 9. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23. doi:10.1007/s12028-012-9695-z